thyroxine has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 22 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Presently, the standard of care for prolactinomas, a type of pituitary adenoma, is dopaminergic agents such as bromocriptine and cabergoline." | 5.46 | Cabergoline-induced fibrosis of prolactinomas: a neurosurgical perspective. ( Chia, YY; Goh, GH; Mohan, N; Teo, K; Ting, E; Yeo, TT, 2017) |
| " Hormonal evaluation showed hyperprolactinemia (50 ng/mL) and hypopituitarism, and the patient needed substitution with hydrocortisone and levothyroxine." | 4.82 | Pituitary apoplexy and idiopathic thrombocytopenic purpura: a new case and review of the literature. ( Bennet, A; Caron, P; Lagarrigue, J; Maïza, JC; Thorn-Kany, M, 2004) |
| " Serum prolactin (PRL), thyroid-stimulating hormone (TSH), thyroxine (free T4), free tri-iodothyronine (free T3), insulin resistance (IR) which was estimated by the homeostasis model assessment, thyroidal microsome (anti-TPO), antithyroglobulin antibodies (TgAb), estradiol (E2), and insulin like growth factor (IGF-1) were evaluated, and thyroid volume was calculated by B-mode doppler USG." | 3.81 | Are there any causes for increased thyroid volume in women with prolactinoma? ( Arduç, A; Berker, D; Doğan, BA; Güler, S; Müslüm Tuna, M; Taşcı, T, 2015) |
| "Thyrotropin-secreting pituitary adenomas (TSHomas) are a rare entity, occurring in one per million people." | 2.72 | ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases. ( De Block, C; De Herdt, C; Philipse, E, 2021) |
| "We report a rare case of giant prolactinoma with a first epileptic seizure due to rapid reduction of the tumor as a complication of dopamine agonist therapy." | 1.51 | Status epilepticus induced by treatment with dopamine agonist therapy for giant prolactinoma: a case report. ( Abe, T; Ebashi, R; Koguchi, M; Masuoka, J; Nakahara, Y; Ogata, A; Shimokawa, S, 2019) |
| "Presently, the standard of care for prolactinomas, a type of pituitary adenoma, is dopaminergic agents such as bromocriptine and cabergoline." | 1.46 | Cabergoline-induced fibrosis of prolactinomas: a neurosurgical perspective. ( Chia, YY; Goh, GH; Mohan, N; Teo, K; Ting, E; Yeo, TT, 2017) |
| "Patients with hyperprolactinaemia have significantly increased thyroid volume, thyroid autoimmunity and nodule prevalence." | 1.39 | Hyperprolactinaemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma. ( Cakal, E; Delibasi, T; Gungunes, A; Karakose, M; Ozbek, M; Sahin, M; Sayki Arslan, M; Topaloglu, O; Tutal, E, 2013) |
| "Diagnosis of a giant macroprolactinoma was made and cabergoline was started." | 1.35 | Misdiagnosis due to the hook effect in prolactin assay. ( Arda, N; Comlekci, A; Men, S; Yener, S; Yesil, S, 2008) |
| "Primary hypothyroidism was evidenced by decreased serum thyroxine (23 nmol/l; 1,77 micrograms/dl) and increased plasma thyroid-stimulating hormone (TSH) levels (108 mU/l)." | 1.28 | [Regression of a pituitary tumor, associated with primary hyperthyroidism, under the effect of 1-thyroxine]. ( Fehér, J; Gláz, E; Kiss, R; Mohari, K; Novák, K; Rácz, K; Tóth, M, 1989) |
| "In cultures of prolactinoma cells from patients normally responsive to bromocriptine therapy (n = 10), considered as controls, 10(-9) mol/L bromocriptine inhibited PRL release by 71 +/- 6% (+/- SE), and the half-inhibitory dose was 7 x 10(-11) mol/L." | 1.28 | Resistance to bromocriptine in prolactinomas. ( Bertrand, P; Delivet, S; Enjalbert, A; Gunz, G; Jaquet, P; Jedynak, CP; Kordon, C; Peillon, F; Pellegrini, I; Rasolonjanahary, R, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.64) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 7 (31.82) | 29.6817 |
| 2010's | 10 (45.45) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| De Herdt, C | 1 |
| Philipse, E | 1 |
| De Block, C | 1 |
| Mohan, N | 1 |
| Chia, YY | 1 |
| Goh, GH | 1 |
| Ting, E | 1 |
| Teo, K | 1 |
| Yeo, TT | 1 |
| Koguchi, M | 1 |
| Nakahara, Y | 1 |
| Ebashi, R | 1 |
| Ogata, A | 1 |
| Shimokawa, S | 1 |
| Masuoka, J | 1 |
| Abe, T | 1 |
| Sayki Arslan, M | 1 |
| Sahin, M | 1 |
| Topaloglu, O | 1 |
| Tutal, E | 1 |
| Karakose, M | 1 |
| Gungunes, A | 1 |
| Cakal, E | 1 |
| Ozbek, M | 1 |
| Delibasi, T | 1 |
| Zhang, H | 1 |
| Geng, N | 1 |
| Wang, Y | 1 |
| Tian, W | 1 |
| Xue, F | 1 |
| Boscolo, M | 1 |
| Baleriaux, D | 1 |
| Bakoto, N | 1 |
| Corvilain, B | 1 |
| Devuyst, F | 1 |
| Querol Ripoll, R | 1 |
| Cámara Gómez, R | 1 |
| Del Olmo García, M | 1 |
| Simal Julián, JA | 1 |
| Merino Torres, JF | 1 |
| Doğan, BA | 1 |
| Taşcı, T | 1 |
| Arduç, A | 1 |
| Müslüm Tuna, M | 1 |
| Berker, D | 1 |
| Güler, S | 1 |
| Yener, S | 1 |
| Comlekci, A | 1 |
| Arda, N | 1 |
| Men, S | 1 |
| Yesil, S | 1 |
| Iglesias, P | 1 |
| Díez, JJ | 1 |
| Cano Megias, M | 1 |
| Iglesias Lozano, P | 1 |
| Ley Urzaiz, L | 1 |
| Katulande, P | 1 |
| Kariyawasam, SS | 1 |
| Senanayake, HM | 1 |
| Weerakkodi, M | 1 |
| Keogh, MA | 1 |
| Wittert, GA | 1 |
| Torpiano, J | 1 |
| Vanderpump, M | 1 |
| Stanhope, R | 1 |
| Morganstein, D | 1 |
| Mendoza, N | 1 |
| Strickland, N | 1 |
| Meeran, K | 1 |
| Maïza, JC | 1 |
| Bennet, A | 1 |
| Thorn-Kany, M | 1 |
| Lagarrigue, J | 1 |
| Caron, P | 1 |
| Orrego, JJ | 1 |
| Minniti, G | 1 |
| Jaffrain-Rea, ML | 1 |
| Lunardi, P | 1 |
| Gulino, A | 1 |
| Tamburrano, G | 1 |
| Jurado, S | 1 |
| Eskildsen, PC | 1 |
| Kruse, A | 1 |
| Kirkegaard, C | 1 |
| Tóth, M | 1 |
| Rácz, K | 1 |
| Novák, K | 1 |
| Kiss, R | 1 |
| Mohari, K | 1 |
| Fehér, J | 1 |
| Gláz, E | 1 |
| Pellegrini, I | 1 |
| Rasolonjanahary, R | 1 |
| Gunz, G | 1 |
| Bertrand, P | 1 |
| Delivet, S | 1 |
| Jedynak, CP | 1 |
| Kordon, C | 1 |
| Peillon, F | 1 |
| Jaquet, P | 1 |
| Enjalbert, A | 1 |
4 reviews available for thyroxine and Adenoma, Prolactin-Secreting, Pituitary
| Article | Year |
|---|---|
ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases.
Topics: Adenoma; Atrial Fibrillation; Chemotherapy, Adjuvant; Goiter; Gonadotropins, Pituitary; Growth Hormo | 2021 |
Van Wyk and Grumbach syndrome: two case reports and review of the published work.
Topics: Child; Female; Humans; Hypothyroidism; Ovarian Cysts; Pituitary Neoplasms; Prolactinoma; Puberty, Pr | 2014 |
Acute aseptic meningitis as the initial presentation of a macroprolactinoma.
Topics: Adult; Anti-Bacterial Agents; Blindness; Cabergoline; Combined Modality Therapy; Ergolines; Fever; H | 2014 |
Pituitary apoplexy and idiopathic thrombocytopenic purpura: a new case and review of the literature.
Topics: Adrenal Cortex Hormones; Humans; Hydrocortisone; Hypopituitarism; Immunoglobulins; Male; Middle Aged | 2004 |
18 other studies available for thyroxine and Adenoma, Prolactin-Secreting, Pituitary
| Article | Year |
|---|---|
Cabergoline-induced fibrosis of prolactinomas: a neurosurgical perspective.
Topics: Adult; Antineoplastic Agents; Cabergoline; Combined Modality Therapy; Diagnosis, Differential; Dopam | 2017 |
Status epilepticus induced by treatment with dopamine agonist therapy for giant prolactinoma: a case report.
Topics: Adult; Anticonvulsants; Cabergoline; Dopamine Agonists; Fatigue; Frontal Lobe; Humans; Hydrocortison | 2019 |
Hyperprolactinaemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma.
Topics: Adult; Autoantibodies; Case-Control Studies; Female; Humans; Hyperprolactinemia; Male; Middle Aged; | 2013 |
[Pituitary apoplexy in a pregnant woman with cystic microprolactinoma].
Topics: Adult; Bromocriptine; Cabergoline; Combined Modality Therapy; Contraindications; Dopamine Agonists; | 2015 |
Are there any causes for increased thyroid volume in women with prolactinoma?
Topics: Adult; Autoantibodies; Estradiol; Female; Humans; Insulin Resistance; Insulin-Like Growth Factor I; | 2015 |
Misdiagnosis due to the hook effect in prolactin assay.
Topics: Antineoplastic Agents; Cabergoline; Diabetes Insipidus, Neurogenic; Diagnostic Errors; Ergolines; Fe | 2008 |
Chronic anemia as first clinical manifestation of a prolactin-secreting pituitary macroadenoma in a male patient.
Topics: Anemia; Antineoplastic Agents; Biomarkers, Tumor; Cabergoline; Chronic Disease; Dopamine Agonists; D | 2011 |
[Therapeutic response to medical treatment in cystic giant prolactinoma].
Topics: Adult; Androgens; Dopamine Agonists; Drug Therapy, Combination; Humans; Male; Pituitary Neoplasms; P | 2012 |
Multicystic ovaries and pituitary pseudo-adenoma associated with primary hypothyroidism.
Topics: Female; Humans; Hypothyroidism; Ovarian Cysts; Pituitary Neoplasms; Pregnancy; Prolactinoma; Thyroxi | 2013 |
Effect of cabergoline on thyroid function in hyperprolactinaemia.
Topics: Cabergoline; Dopamine Agonists; Ergolines; Humans; Pituitary Neoplasms; Prolactinoma; Retrospective | 2002 |
The management of sellar masses: not all pituitary tumours require surgery for diagnosis and/or therapy.
Topics: Bromocriptine; Child; Dopamine Agonists; Female; Humans; Magnetic Resonance Imaging; Male; Pituitary | 2004 |
Low TSH in a patient with primary hypothyroidism.
Topics: Aged; Biomarkers; Diagnostic Errors; Female; Humans; Hypopituitarism; Hypothyroidism; Pituitary Neop | 2005 |
Visual vignette. Macroprolactinoma.
Topics: Adult; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Testo | 2008 |
15-year-old boy with ocular palsy and headache. Invasive macroprolactinoma.
Topics: Adolescent; Bromocriptine; Cortisone; Dopamine Agonists; Eye Diseases; Headache; Humans; Male; Pitui | 1996 |
[A 50-year old patient with macroprolactinoma].
Topics: Aminoquinolines; Anti-Inflammatory Agents; Diagnosis, Differential; Dopamine Agonists; Humans; Hydro | 2002 |
The pituitary-thyroid axis in patients with pituitary disorders.
Topics: Adenoma; Adult; Aged; Craniopharyngioma; Euthyroid Sick Syndromes; Female; Follow-Up Studies; Humans | 1989 |
[Regression of a pituitary tumor, associated with primary hyperthyroidism, under the effect of 1-thyroxine].
Topics: Adult; Galactorrhea; Humans; Hypothyroidism; Male; Pituitary Neoplasms; Prolactinoma; Remission Indu | 1989 |
Resistance to bromocriptine in prolactinomas.
Topics: 17-Hydroxycorticosteroids; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adolescent; Adult; Bromoc | 1989 |